U.S. markets closed
  • S&P Futures

    3,413.50
    -19.00 (-0.55%)
     
  • Dow Futures

    27,981.00
    -153.00 (-0.54%)
     
  • Nasdaq Futures

    11,633.00
    -58.25 (-0.50%)
     
  • Russell 2000 Futures

    1,595.70
    -7.40 (-0.46%)
     
  • Crude Oil

    39.80
    -0.23 (-0.57%)
     
  • Gold

    1,924.30
    -5.20 (-0.27%)
     
  • Silver

    25.11
    -0.13 (-0.52%)
     
  • EUR/USD

    1.1854
    -0.0013 (-0.11%)
     
  • 10-Yr Bond

    0.8160
    +0.0190 (+2.38%)
     
  • Vix

    28.65
    -0.70 (-2.39%)
     
  • GBP/USD

    1.3139
    -0.0005 (-0.04%)
     
  • USD/JPY

    104.6670
    +0.1070 (+0.10%)
     
  • BTC-USD

    12,871.67
    +1,814.66 (+16.41%)
     
  • CMC Crypto 200

    257.67
    +12.78 (+5.22%)
     
  • FTSE 100

    5,776.50
    -112.72 (-1.91%)
     
  • Nikkei 225

    23,507.92
    -131.54 (-0.56%)
     

Legend Biotech (LEGN) in Focus: Stock Moves 6.2% Higher

Zacks Equity Research
·2 mins read

Legend Biotech Corporation LEGN was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $27.50 –$35.06 in the past one-month time frame, witnessed a sharp increase yesterday.
 
The company has seen one negative estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Legend Biotech currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive. 

Legend Biotech Corporation Sponsored ADR Price

Legend Biotech Corporation Sponsored ADR Price
Legend Biotech Corporation Sponsored ADR Price

Legend Biotech Corporation Sponsored ADR price | Legend Biotech Corporation Sponsored ADR Quote

Investors interested in the Medical - Biomedical and Genetics industry may consider QIAGEN N.V. QGEN, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
QIAGEN N.V. (QGEN) : Free Stock Analysis Report
 
Legend Biotech Corporation Sponsored ADR (LEGN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research